A Phase 2 Multi-center, Open-label, Switch-over Trial to Evaluate the Safety and Efficacy of Abcertin® in Patients with Type 1 Gaucher Disease

Gaucher disease is a lysosomal storage disease for which enzyme replacement therapy has proven to be effective. A switch-over clinical trial was performed to evaluate the efficacy and safety of Abcertin® (ISU Abxis, Seoul, Korea) in subjects with type 1 Gaucher disease who were previously treated wi...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Korean Med Sci
Main Authors: Choi, Jin-Ho, Lee, Beom Hee, Ko, Jung Min, Sohn, Young Bae, Lee, Jin-Sung, Kim, Gu-Hwan, Heo, Sun Hee, Park, June-Young, Kim, Yoo-Mi, Kim, Ja-Hye, Yoo, Han-Wook
פורמט: Artigo
שפה:Inglês
יצא לאור: The Korean Academy of Medical Sciences 2015
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4366957/
https://ncbi.nlm.nih.gov/pubmed/25829804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2015.30.4.378
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים